Disclosure of Pregnancy-Related Privacy Risks in Clinical Research Post-Dobbs.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 41733400.
- Also identified by DOI 10.1056/EVIDra2500239.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
AbstractInterventional clinical research often involves risks to participants of reproductive potential, requiring pregnancy testing, contraception, and reporting of incidental pregnancies. Since the <i>Dobbs v. Jackson Women's Health Organization</i> (2022) decision that eliminated the constitutional right to abortion, these routine research practices present new risks to participants, clinicians, and investigators. This review examines the emerging reproductive privacy concerns in clinical research post-Dobbs and provides practical considerations for investigators and institutional review boards navigating this evolving legal environment.
Medical subject headings
- Disclosure
- Privacy
- Biomedical Research